Author

I. Fournier

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Proteomic Profiling of Nodal T-Follicular Helper Cell Lymphoma Reveals Distinct Biological Signatures and Improves Prognostic Stratification Beyond the IPI.

Nodal T-follicular helper cell lymphoma (nTFHL), most commonly of angioimmunoblastic type, exhibits heterogeneous clinical outcomes that are not fully explained by current clinical and biological variables. While genetic alterations have been extensively investigated, its proteomic landscape remains largely unexplored....

D. Beauvais, Y. Zirem, T. Cardon et al. · American journal of hematolo... · 0 citations

Open access Aug 2026

Label-free proteomic profiling identifies ECM-related alterations across regeneration states in human peripheral axonal neuropathies

Understanding the multiple mechanisms underlying peripheral nerve regeneration in humans is crucial for developing effective therapies for peripheral axonal neuropathies. Although in vitro and in vivo studies have provided significant insights, human studies exploring the composition of proteome remain limited. The ECM...

M. Damato, S. Aboulouard, Velia La Pesa et al. · Journal of physiology and bi... · 0 citations

Open access Aug 2026

Clone-by-Clone Therapy Guidance in Luminal Breast Cancer via Spatial Proteomics and Patient-Derived Tumoroid.

Breast cancer (BC) remains the leading cause of cancer-related death among women worldwide, with 2.26 million new cases and ∼685,000 deaths reported in 2020 (Globocan 2020). A major challenge in treating BC, particularly luminal subtypes, is the pronounced molecular heterogeneity both between patients and within indivi...

Laurine Lagache, Antonella Raffo-Romero, M. Duhamel et al. · Molecular & Cellular Proteom... · 0 citations